About

A society for the scientists shaping cancer therapy.

The NanoTME Society grew from the NanoTME conference series — a recurring meeting that, for the first time, put nanomedicine engineers and tumor microenvironment biologists in the same room. What started as a conversation became a global community.

The Society

Advancing a rapidly evolving field.

The tumor microenvironment shapes how cancers grow, spread, and respond to therapy. Nanomedicine offers an unprecedented set of tools to act within that environment — precisely, selectively, and adaptively. The NanoTME Society exists to accelerate the exchange between these two disciplines, and to translate that exchange into better outcomes for patients.

Scientific collaboration

Convening nano-engineers, immunologists, oncologists and clinicians around shared questions and shared standards.

Translational research

Carrying discoveries across the gap that separates the bench from the bedside.

Education & training

Supporting the next generation through conferences, workshops and mentorship programs.

International networking

A working network of institutions across academia, hospitals and industry.

Society leadership

Founded by scientists. Convened for the community.

Prof. dr. Yuval Shaked

Co-chair

Prof. dr. Yuval Shaked

A long-standing research programme on the systemic and microenvironmental response of the host to anti-cancer therapy, and on the mechanisms by which treatment shapes resistance and metastasis.

Research focus

Host response to anti-cancer therapy · tumor microenvironment · resistance mechanisms

“The interface between nanomedicine and the tumor microenvironment is where the most consequential questions in modern oncology are now being asked. The Society exists so that those questions can be addressed together.”
Prof. dr. Jai Prakash

Co-chair

Prof. dr. Jai Prakash

A research programme on stromal targeting and engineered nanomedicine for solid tumors, with a translational orientation across academia, clinic and industry.

Research focus

Targeted nanomedicine · stromal targeting · advanced 3D tumor models

“NanoTME was conceived as a working community. Three editions in, it has become the place where engineers, biologists and clinicians can speak the same language — and design experiments together.”

Join us

A scientific community for the next chapter of cancer research.

Affiliation with the NanoTME Society places investigators, clinicians and partners within an international scientific community working at the interface of nanomedicine and the tumor microenvironment.